Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Is Mediastinal Blood Pool SUV Ratio Valid in Identification of Malignancy in Comparison to Liver SUV Ratio?

NCT05258045 is registered in ClinicalTrials.gov with Assiut University as lead sponsor.

NCT NCT05258045
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05258045 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Is Mediastinal Blood Pool SUV Ratio Valid in Identification of Malignancy in Comparison to Liver SUV Ratio?
Lead sponsor
Assiut University
Phase
Observational
Overall status
Unknown status
Start date
June 1, 2022
Completion date
December 30, 2023
Enrollment
55 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

validity of blood pool suv ratio in identification of malignancy in case of diseased liver